Hidalgo Nursing and Rehab: Antipsychotic Misuse Findings - TX
The findings came out of a complaint inspection at Hidalgo Nursing and Rehabilitation Center, completed April 29, 2026. The single deficiency cited involved the use of Zyprexa, a brand-name antipsychotic, prescribed for a resident identified only as Resident 1. What inspectors uncovered in the course of that investigation touched on something the facility's own nurses and its director of nursing acknowledged plainly: giving an antipsychotic to a resident with Alzheimer's or dementia under the wrong indication is not a clinical error in the ordinary sense. It is, by the staff's own definition, a chemical restraint.
The nurse practitioner who wrote the Zyprexa order, identified in the inspection report as MH NP F, listed psychosis as the indication. That much was documented. What was not documented, at least not in any record the director of nursing could locate, was the diagnosis of schizophrenia that a second mental health nurse practitioner, MH NP E, had stated and written as part of Resident 1's history.
"She said MH NP E had stated and wrote that Resident 1 had a history of schizophrenia, but she could not locate that diagnosis anywhere," the inspection report states, describing what the director of nursing told inspectors during an interview on the afternoon of April 29.
A day or two after the Zyprexa order was written, the facility received paperwork from another facility indicating Resident 1 had a diagnosis of Bipolar disorder. That paperwork arrived after the antipsychotic had already been ordered and entered into the system.
The sequence matters. An order went in. The indication was psychosis. The supporting diagnosis, schizophrenia, was cited by one nurse practitioner but could not be found in the clinical record. The patient's actual documented psychiatric history, bipolar disorder, arrived afterward. And the drug, in the meantime, had been prescribed and administered under a justification that the facility's own director of nursing could not substantiate when she went looking for it.
Two licensed vocational nurses interviewed by inspectors on the same day laid out exactly what is at stake when an antipsychotic is ordered for a resident with a dementia diagnosis under an indication that doesn't hold up. LVN A said that altered mental status, for example, would be an inappropriate indication for an antipsychotic in a resident with Alzheimer's or dementia. She said if such a drug were given under an inappropriate indication, the negative effect would be that it could worsen whatever symptoms the resident was already experiencing. Then she said something more direct.
There is a black box warning on antipsychotics, she told inspectors. If an antipsychotic is given to a resident with Alzheimer's or dementia psychosis, it increases the risk of death.
She said that an antipsychotic ordered for a resident with Alzheimer's or dementia under an inappropriate indication would need to be clarified with the prescribing doctor or nurse practitioner. She said the negative outcome of failing to do that would be a chemical restraint.
LVN B, interviewed separately, described the mechanics of how antipsychotic orders move through the system at the facility. If a nurse practitioner or doctor gives a verbal order for an antipsychotic, it is the nurse who took the order who enters it into the computer. If that nurse has questions, LVN A said, the practice is to call back and clarify. The inspection report does not indicate that any such clarification call was made regarding the Zyprexa order for Resident 1.
The director of nursing told inspectors that nurses at the facility had already been trained on the appropriate forms for antipsychotics and on appropriate indications, and that new antipsychotic orders were reviewed at morning meetings. The inspection report does not reflect what, if anything, that morning meeting review produced in Resident 1's case, or whether anyone flagged the psychosis indication as requiring verification before the drug was administered.
The facility's own written policy, dated March 5, 2025, states that psychotropic medications are to be used only when a practitioner determines the medication is appropriate to treat a specific, diagnosed, and documented condition. The word documented carries weight here. A diagnosis that one nurse practitioner stated verbally and wrote down, but that the director of nursing cannot locate in the clinical record when inspectors come asking, is not a documented condition in any meaningful sense.
The same policy defines a chemical restraint as any drug used for staff convenience or discipline rather than to treat medical symptoms, and extends that definition to situations where a psychotropic medication might be approved for certain symptoms but is given without first attempting non-pharmacological interventions, unless those interventions are clinically contraindicated. The inspection report does not indicate that any non-pharmacological approaches were documented or attempted before the Zyprexa order was written.
The FDA's black box warning that LVN A referenced is one of the most serious cautions in American prescribing. It exists because clinical trials found that elderly patients with dementia-related psychosis who were given antipsychotic drugs died at a higher rate than those given a placebo. The causes were primarily cardiovascular, including heart failure and sudden death, and infectious, including pneumonia. The warning does not prohibit use. It requires that the risks be weighed against a genuine, documented clinical need.
What inspectors found at Hidalgo is a case where that weighing process broke down at nearly every checkpoint. The prescribing nurse practitioner listed an indication. A second nurse practitioner introduced a diagnosis that could not be verified in the record. The facility received conflicting information about the patient's actual psychiatric history only after the order was already in. The nurses who entered and carried out the order did not document any call to clarify the indication. And when the director of nursing was asked to show inspectors where the schizophrenia diagnosis lived in Resident 1's chart, she could not find it.
CMS rated the deficiency as causing minimal harm or the potential for actual harm, and noted that few residents were affected. The inspection report does not describe Resident 1's condition after receiving the drug, whether they experienced adverse effects, or what ultimately happened to the Zyprexa order once the facility received the bipolar diagnosis paperwork from the transferring facility.
What the report does leave on the record is the director of nursing's own account of what happened, given to inspectors at 6:05 in the evening on the last day of the inspection. She confirmed the sequence. She confirmed the paperwork came in after the order. She confirmed she could not find the diagnosis that had been used to frame the prescription.
Resident 1 had already received the drug by then.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Hidalgo Nursing and Rehabilitation Center from 2026-04-29 including all violations, facility responses, and corrective action plans.
Download the official CMS inspection PDF from Medicare.gov
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: September 19, 2026 · Our methodology
Hidalgo Nursing and Rehabilitation Center in Edinburg, TX was cited for violations during a health inspection on April 29, 2026.
The findings came out of a complaint inspection at Hidalgo Nursing and Rehabilitation Center, completed April 29, 2026.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.